T1	CHEM 66 75	nivolumab
#1	AnnotatorNotes T1	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T2	Route 90 105	vía intravenosa
T3	Route 108 122	vía subcutánea
T4	DISO 129 137	melanoma
#2	AnnotatorNotes T4	C0025202; melanoma; Neoplastic Process
T5	DISO 143 159	cáncer de vejiga
#3	AnnotatorNotes T5	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T6	CHEM 214 223	nivolumab
#4	AnnotatorNotes T6	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	Route 238 253	vía intravenosa
T8	Route 255 258	i.v
T9	Route 263 277	vía subcutánea
T10	Route 279 283	s.c.
T11	LIVB 288 301	participantes
T12	DISO 306 314	melanoma
#5	AnnotatorNotes T12	C0025202; melanoma; Neoplastic Process
T13	PROC 315 323	resecado
#6	AnnotatorNotes T13	C0728940; Excision; Therapeutic or Preventive Procedure
T14	DISO 351 379	carcinoma urotelial invasivo
T15	PROC 380 388	resecado
#7	AnnotatorNotes T15	C0728940; Excision; Therapeutic or Preventive Procedure
T16	ANAT 420 426	vejiga
#8	AnnotatorNotes T16	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T17	DISO 449 457	Melanoma
#9	AnnotatorNotes T17	C0025202; melanoma; Neoplastic Process
T18	DISO 460 482	carcinoma en la vejiga
#10	AnnotatorNotes T18	C0699885; Carcinoma of bladder; Neoplastic Process
T19	DISO 508 516	Melanoma
#11	AnnotatorNotes T19	C0025202; melanoma; Neoplastic Process
T20	PROC 517 525	resecado
#12	AnnotatorNotes T20	C0728940; Excision; Therapeutic or Preventive Procedure
T21	DISO 556 589	carcinoma urotelial (CU) invasivo
T22	PROC 590 598	resecado
#13	AnnotatorNotes T22	C0728940; Excision; Therapeutic or Preventive Procedure
T23	LIVB 630 643	participantes
T24	PROC 673 694	tratamiento adyuvante
#14	AnnotatorNotes T24	C0677850; Adjuvant therapy; Therapeutic or Preventive Procedure
T25	DISO 702 710	melanoma
#15	AnnotatorNotes T25	C0025202; melanoma; Neoplastic Process
T26	DISO 713 715	CU
#16	AnnotatorNotes T26	C0009324; Ulcerative Colitis; Disease or Syndrome
T27	DISO 720 737	invasión muscular
T28	ANAT 754 760	vejiga
#17	AnnotatorNotes T28	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T29	DISO 765 773	Melanoma
#18	AnnotatorNotes T29	C0025202; melanoma; Neoplastic Process
T30	PROC 775 784	resección
#19	AnnotatorNotes T30	C0728940; Excision; Therapeutic or Preventive Procedure
T31	ANAT 841 847	Vegiga
T32	Neg_cue 853 855	no
T33	Negated 871 912	quimioterapia neoadyuvante con cisplatino
T34	PROC 871 897	quimioterapia neoadyuvante
T35	PROC 950 976	quimioterapia neoadyuvante
T36	DISO 1077 1105	melanoma ocular o de mucosas
T37	DISO 1108 1139	CU de vías urinarias superiores
T38	ANAT 1141 1147	uréter
#20	AnnotatorNotes T38	C0041951; Ureter; Body Part, Organ, or Organ Component | C0555807; Ureter NEC; Body Part, Organ, or Organ Component | C1281572; Entire ureter; Body Part, Organ, or Organ Component
T39	ANAT 1149 1161	pelvis renal
#21	AnnotatorNotes T39	C0227666; Renal pelvis; Body Part, Organ, or Organ Component | C1284489; Entire renal pelvis; Body Part, Organ, or Organ Component
T40	DISO 1164 1169	NMIBC
#22	AnnotatorNotes T40	Non-Muscle Invasive Bladder Neoplasms (C1336527)
T41	DISO 1172 1209	Metástasis en el SNC o leptomeníngeas
T42	Neg_cue 1210 1212	no
T43	PROC 1213 1221	tratadas
T44	Negated 1213 1221	tratadas
T45	Neg_cue 1224 1226	no
T46	PROC 1227 1236	resecadas
#23	AnnotatorNotes T46	C0728940; Excision; Therapeutic or Preventive Procedure
T47	Negated 1227 1236	resecadas
T48	Neg_cue 1239 1241	No
T49	PROC 1256 1267	tratamiento
#24	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	CHEM 1279 1305	agentes inmuno-oncológicos
T51	Negated 1279 1305	agentes inmuno-oncológicos
T52	PROC 44 62	Estudio del cambio
T53	Negated 1256 1267	tratamiento
T54	CHEM 902 912	cisplatino
T55	CHEM 981 991	cisplatino
T56	PROC 181 210	Estudio de fase II del cambio
T57	Quantifier_or_Qualifier 324 348	estadio III o estadio IV
T58	Quantifier_or_Qualifier 371 379	invasivo
T59	Observation 392 403	alto riesgo
T60	Quantifier_or_Qualifier 526 549	estadio IIIA/B/C/D o IV
T61	Quantifier_or_Qualifier 581 589	invasivo
T62	Quantifier_or_Qualifier 788 806	estadio IIIA/B/C/D
T63	Quantifier_or_Qualifier 809 819	estadio IV
T64	Observation 914 922	pT3-pT4a
T65	Observation 925 928	pN+
T66	Observation 996 1002	2-pT4a
T67	Observation 1008 1010	+.
T68	CONC 1013 1017	ECOG
T69	Result_or_Value 1021 1026	0 o 1
T70	Result_or_Value 1028 1047	Mayor o igual a 18.
T71	Patient 288 301	participantes
T72	Patient 630 643	participantes
T73	Future 685 694	adyuvante
T74	History_of 775 784	resección
T75	History_of 871 897	quimioterapia neoadyuvante
T76	History_of 902 912	cisplatino
T77	History_of 950 976	quimioterapia neoadyuvante
T78	History_of 981 991	cisplatino
T79	History_of 1256 1267	tratamiento
T80	History_of 1279 1305	agentes inmuno-oncológicos
